To further support the evidence that FGFR2 activation and nuclear translocation were ligand-dependent, we treated RS4;11 leukemia cells with PD173074, a synthetic compound belonging to the pyrido (2,3-d) pyrimidine class. Here, FGFR2 is linked to leukemia.